Ruiz-Argüelles A, Pérez-Romano B

Language: Spanish
References: 22
Page: 82-90
PDF size: 270.21 Kb.

ABSTRACT

Immunophenotyping of hematological malignancies has proved useful for the diagnosis, classification, prognosis and monitoring of several oncohematological conditions. In order to standardize criteria for the indication, selection of reagents and methods, and interpretation of results, it has been necessary to organize working groups or consensus conferences, whose recommendations have resulted in the comparability and compatibility of information amongst many laboratories and institutions. Two Latin American Consensus Conferences for Immunophenotyping of Hematological Malignancies have been held so far, and the recommendations of the latter are still pertinent; however, in a rather short term future they should be replaced by new guidelines. This paper reviews on the basis and validity of consensus recommendations.

REFERENCES

1. Duque RE, Orfao A. Utilidad del inmunofenotipo en el diagnóstico y clasificación de las leucemias crónicas. En: Actualización en Leucemia. Ruiz-Argüelles GJ, San Miguel JF (editores). México: Panamericana, 1996; p:89-96.

2. NCCLS Document H43-P. Clinical applications of flow cytometry: Immunophenotyping of leukemic cells; proposed guideline. 1993; 23: 1-107

3. Lanza F, for the European Working Group on Leukemia Immunophenotyping: Towards standardization in immunophenotyping in hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Eur J Hitochem 1996; 40 Suppl 1: 7-14.

4. San Miguel JF, Duque RE. Utilidad del inmunofenotipo en el diagnóstico y clasificación de las leucemias agudas. En: Actualización en Leucemia. Ruiz-Argüelles GJ, San Miguel JF (editores). México: Panamericana, 1996;p:25-34.

5. Rothe G, Schmitz G, Adorf D. Consensus protocols for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 1996;10: 877-895.

6. Tbakhi A, Edinger M, Myles J, Pohlman B, Tubbs R. Flow cytometric immunophenotyping of non Hodgkin’s lymphomas and related disorders. Cytometry 1996;25:113-124.

7. Ruiz-Argúelles GJ, San Miguel JF. Cell surface markers in multiple myeloma. Mayo Clin Proc 1994;69:684-690.

8. Bernard A, Boumsell L, Dausset J (eds). Luecocyte Typing. Berlín: Springer Verlag, 1984.

9. Nguyen D, Diamond LW, Braylan RC. Flow cytometry in hematopathology. A visual approach to data analysis and interpretation. Humana Press. New Jersey, 2007.

10. Orfao A, Ruiz-Argüelles A, Lacombe F, Ault K, et al. Flow cytometry: Its applications in hematology. Haematologica 1995;80:69.

11. Orfao A, Schmitz G, Brando B, Ruiz-Argüelles A, et al. Clinically useful information provided by the flow cytometric immunophenotyping of haematological malignancies: A comprehensive review. Clin Chem 1999;45: 1708.

12. Stewart C, Behm FG, Carey JL, Cornbleet J, et al. USCanadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations. Cytometry 1997;30:231-235.

13. Ruiz-Argüelles A, Duque RE, Orfao A. Report on the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia. Cytometry 1998;34:39-42.

14. Ruiz-Argüelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A. Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry 2005;708: 39-44.

15. Davis BH, Holden JT, Bene MC, Borowitz MJ, et al. 2006 Bethesda international consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications. Cytometry 2007;72B:S5-S13.

16. Falini B, Flenghi L, Fagioli M, Lo Cocco F, et al. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood 1997;90:4046-453.

17. Ruiz-Argüelles GJ, López-Martínez B, Lobato-Mendizábal E, Ruiz-Delgado GJ. An addition to geographic hematology: Chronic myeloproliferative diseases are infrequent in Mexican Mestizos. Int J Hematol 2002;75:499.

18. Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes Núñez V, Gómez-Rangel JD, Ruiz-Delgado GJ. More on geographic hematology: The breakpoint cluster regions of the PML/RARa fusion gene in Mexican mestizo patients with promyelocytic leukemia are different from those in Caucasians. Leukemia Lymphoma 2004;45:1365-1368.

19. Ruiz-Argüelles GJ, Cantú-Rodríguez OG, Gómez-Almaguer D, Cortés-Franco J, et al. Hairy cell leukemia is infrequent in México and has a geographic distribution. Am J Hematol 1996;52:316.

20. Ruiz-Argüelles GJ, Fernández-Lara D, Estrada-Gómez R, Manzano C, et al. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: Prognostic significance. Lab Hematol 2007;13:22-26.

21. Veltroni M, De-Zen L, Colomba-Sanzari M, Maglia O, Dworzak MN, Ratei R, Biondi A, Basso G, Gaipa G, on behalf of the I-BFM-ALL-FCM-MRD-study group. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphoblastic leukemia. Haematologica/J Hematol 2003;88:1245-1251.

22. Chen JS, Coustan-Smith E, Suzuki T, Neale GA, et al. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood 2001;97:2115-2120.